EUVIMEDEUVIMED entdecken
Open Access

BMP1 Appears to be Involved in GPER1-mediated Progression and Tamoxifen Resistance of Luminal A Breast Cancer Cells

Katharina Wert, Johanna Jentsch, Julia Gallwas, Carsten Gründker

Cancer Genomics - Proteomics · 2025

DOI: 10.21873/cgp.20546 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Cancer Genomics - Proteomics, 2025. Verfasst von Katharina Wert und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Gynecology and Obstetrics, University Medical Center Göttingen, Göttingen, Germany. Hauptthemen laut MEDLINE: Tamoxifen, Breast Neoplasms, Receptors, G-Protein-Coupled, Drug Resistance, Neoplasm. Der Volltext ist frei in PubMed Central verfügbar.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

BACKGROUND/AIM: Bone morphogenetic protein 1 (BMP1) plays a role in the activation of both transforming growth factor-β (TGFβ) and BMP signaling pathways. We investigated whether BMP1 is involved in G-protein coupled estrogen receptor 1 (GPER1)-regulated progression of luminal A-type breast cancer cells. MATERIALS AND METHODS: Publicly available transcriptomic data from MCF7 breast cancer cells treated with the selective GPER1 agonist G1 were analyzed and the results, in particular the altered BMP1 expression, were validated by qPCR. Signs of epithelial-mesenchymal transition (EMT) were visualized by immune cytology. Invasion was quantified by modified Boyden chamber assay. Tamoxifen-resistant sublines of the MCF7 and T47D cell lines were established. RESULTS: Activation of GPER1 by the agonist G1 increased the expression of BMP1 in MCF7 and T47D luminal A breast cancer cells. In addition, EMT and invasion was enhanced after GPER1 activation. This effect could be prevented in part by the BMP1 inhibitor UK383367. Tamoxifen-resistant MCF7-TR and T47D-TR cells exhibited higher BMP1 expression, signs of EMT and enhanced invasiveness compared to their tamoxifen-sensitive wild type. Blocking GPER1 in MCF7-TR and T47D-TR cells using the antagonist G36 led to reduction in BMP1 expression, a slight decrease in EMT, reduced cell invasion, and increased sensitivity to tamoxifen. CONCLUSION: BMP1 appears to be involved in GPER1-mediated progression of luminal A breast cancer cells. In addition, BMP1 may play a role in tamoxifen-resistance.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

TamoxifenBreast NeoplasmsReceptors, G-Protein-CoupledDrug Resistance, NeoplasmReceptors, EstrogenBone Morphogenetic Protein 1HumansFemaleDisease ProgressionEpithelial-Mesenchymal TransitionMCF-7 CellsCell Line, TumorGene Expression Regulation, NeoplasticAntineoplastic Agents, Hormonal

Stichwörter der Autor:innen

BMP1Bone morphogenetic protein 1G-protein coupled estrogen receptor 1GPER1luminal A breast cancertamoxifen-resistance

Substanzen

TamoxifenReceptors, G-Protein-CoupledGPER1 protein, humanReceptors, EstrogenBone Morphogenetic Protein 1Antineoplastic Agents, Hormonal

Autor:innen und Institutionen

  • Department of Gynecology and Obstetrics, University Medical Center Göttingen, Göttingen, Germany.
  • Department of Gynecology and Obstetrics, University Medical Center Göttingen, Göttingen, Germany grundker@med.uni-goettingen.de.

Zitieren

APA

Wert, K., Jentsch, J., Gallwas, J., & Gründker, C. (2025). BMP1 Appears to be Involved in GPER1-mediated Progression and Tamoxifen Resistance of Luminal A Breast Cancer Cells. Cancer Genomics - Proteomics. https://doi.org/10.21873/cgp.20546

Vancouver

Wert K, Jentsch J, Gallwas J, Gründker C. BMP1 Appears to be Involved in GPER1-mediated Progression and Tamoxifen Resistance of Luminal A Breast Cancer Cells. Cancer Genomics - Proteomics. 2025. doi:10.21873/cgp.20546

BibTeX
@article{Wert2025,
  author = {Wert, Katharina and Jentsch, Johanna and Gallwas, Julia and Gründker, Carsten},
  title = {BMP1 Appears to be Involved in GPER1-mediated Progression and Tamoxifen Resistance of Luminal A Breast Cancer Cells},
  journal = {Cancer Genomics - Proteomics},
  year = {2025},
  doi = {10.21873/cgp.20546}
}
Kostenlos starten →